YAP1 and McLeod neuroacanthocytosis syndrome: Pharmacologic inhibition of YAP1 activity with verteporfin suppressed cell viability and YAP1 target gene expression in MLS cell lines, and the growth‐inhibitory effects of YAP1 knockdown or verteporfin treatment could be recapitulated in MLS cell line‐based xenograft models.